Portal de investigación
A Retrospective Observational Chart Review Study Evaluating the Burden of Illness and Treatment Patterns in Hereditary Angioedema Type I and II.
Datos básicos
- Código:
- TAK-743-4009
- Protocolo:
- TAK-743-4009
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2022
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Resultados del Ensayo Clínico
Anti-Mi-2 Dermatomyositis with ulcerative plaques.
Palacios-Diaz RD; (...); Botella-Estrada, Rafael
Article. 10.1093/rheumatology/keac180. 2022
Clinical Features and Outcomes Associated with Bronchial Asthma Among COVID-19 Hospitalized Patients.
Diaz, Miguel Angel; (...); De Diego, Alfredo
Article. 10.2147/JAA.S354082. 2022
Correlation between total ige results in newly released multiplex allergy panel and fluoroenzimoimmune single-parameter assay. characteristics of the studied population
Landaveri, Sanchez L.; (...); Catalan, Cacares N.
Meeting Abstract. 2021
Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain.
Guilarte M; (...); IOS Study Group
Article. 10.1186/s13223-021-00641-3. 2021
Multiple pilomatricomas in a child with xeroderma pigmentosum: Coincidence or association?
Palacios-Diaz RD; (...); Botella-Estrada R
Article. 10.1111/pde.14924. 2022
Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration
Cisneros-Serrano, C.; (...); Chiner, E.
Article. 10.1016/j.rce.2022.11.008. 2023
Spanish multidisciplinary consensus on the characteristics of severe asthma patients on biologic treatment who are candidates for at-home administration.
Cisneros-Serrano C; (...); Chiner E
Article. 10.1016/j.rceng.2022.11.001. 2022